Alexandra MacLean

Insider Reports History

Entity
Individual
Location
C/O Avenue Therapeutics, Inc., 2 Gansevoort Street, 9 Th Floor, New York, NC
Signature
/s/ David Jin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexandra MacLean:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AVENUE THERAPEUTICS, INC. Chief Executive Officer, Director COMMON STOCK, PAR VALUE $0.0001 170K $23.8K $0.14 Sep 23, 2024 Direct

Insider Reports Filed by Alexandra MacLean

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATXI AVENUE THERAPEUTICS, INC. Sep 23, 2024 1 $0 4 Sep 25, 2024 Chief Executive Officer, Director
ATXI AVENUE THERAPEUTICS, INC. Jun 29, 2023 1 $0 4 Jul 3, 2023 Chief Executive Officer, Director
ATXI AVENUE THERAPEUTICS, INC. Aug 1, 2022 0 $0 3 Aug 3, 2022 Chief Executive Officer